Biogen (BIIB) ALZ Drug Has 0% Chance of Winning Approval: Raymond James - Bloomberg

October 22, 2019 3:50 PM EDT
Get Alerts BIIB Hot Sheet
Price: $234.72 +3.48%

Rating Summary:
    22 Buy, 19 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 10 | Down: 12 | New: 31
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Biogen (NASDAQ: BIIB) ALZ Drug Has 0% Chance of Winning Approval: Raymond James - Bloomberg



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Hot Comments, Trader Talk

Related Entities

Raymond James